New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 10, 2014
10:47 EDTKOG, PIP, IPXL, ADP, EWH High option volume stocks: KOG PIP IPXL ADP EWH
News For KOG;PIP;IPXL;ADP;EWH From The Last 14 Days
Check below for free stories on KOG;PIP;IPXL;ADP;EWH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2014
16:25 EDTKOGKodiak Oil & Gas reports Q2 EPS 8c, consensus 18c
Reports Q2 revenue $300M, consensus $283.23M.
07:36 EDTADPADP sees FY15 EPS up 11%-13% from FY14 EPS of $3.14
Subscribe for More Information
07:35 EDTADPADP reports Q4 adjusted EPS 63c, consensus 63c
Subscribe for More Information
July 30, 2014
15:40 EDTADPNotable companies reporting before tomorrow's open
Subscribe for More Information
10:00 EDTIPXLOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:07 EDTIPXLImpax downgraded to Hold from Buy at WallachBeth
Subscribe for More Information
July 29, 2014
12:30 EDTIPXLImpax downgraded to Market Perform from Outperform at Cowen
Subscribe for More Information
11:37 EDTEWHHigh option volume stocks
Subscribe for More Information
08:18 EDTIPXLImpax announces FDA performs inspection on Taiwan facility
Impax announced that the FDA performed a general GMP inspection and a Pre-Approval Inspection for RYTARYTM at the company's Taiwan manufacturing facility from July 21 to July 26. At the conclusion of the inspection, the FDA issued a Form 483 with ten inspectional observations. The Taiwan facility was approved for product manufacturing by the FDA in September 2009 and by Taiwan FDA in July 2010. The facility currently manufactures 12 products for distribution in the United States. The FDA did not provide any status or classification to these observations and will wait until they have received and reviewed the company's response to provide this information. The Ccmpany has also not been informed by the FDA of the impact this Form 483 may have on RYTARY's October 9 review date under the Prescription Drug User Fee Act.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use